A nonsteroidal anti-inflammatory drug (nsaid) that inhibits platelet aggregation (blood clotting).
An antiplatelet agent that inhibits platelet aggregation by a different mechanism than aspirin.
Secondary prevention of stroke and systemic embolism in patients with atrial fibrillation.
Secondary prevention of stroke and other thromboembolic events in patients with a history of stroke or transient ischemic attack (TIA).
Aspirin irreversibly inhibits cyclooxygenase (COX) enzymes, reducing thromboxane A2 production, a potent platelet aggregator. Dipyridamole inhibits adenosine uptake and phosphodiesterase, increasing cAMP levels in platelets and reducing their aggregation. The combination provides a synergistic antiplatelet effect.
Store at room temperature (68-77°F or 20-25°C) in a tightly closed container, away from moisture and direct sunlight. Keep out of reach of children.
The dosage and frequency of Aspirin + Dipyridamole should always be determined by a healthcare professional and will vary depending on the individual patient's condition and medical history.
Always follow the instructions provided by your doctor or pharmacist carefully.
Bleeding (gastrointestinal bleeding, nosebleeds, bruising): This is a significant risk, especially with higher doses.
Gastrointestinal upset (nausea, vomiting, heartburn, stomach pain)
Headache
Dizziness
Rash
Allergic reactions (rare but potentially severe).
Avoid excessive alcohol consumption, as it can increase the risk of gastrointestinal bleeding.
May cause dizziness. Avoid driving or operating machinery if affected.
Consult your doctor before use. Use is generally discouraged during pregnancy and breastfeeding.
Not typically used in children.
Use with caution in patients with kidney disease. May require dose adjustment.
Use with caution in patients with liver disease. May require dose adjustment.
Please consult your doctor or pharmacist for specific product information and detailed references.
